Literature DB >> 27480879

The utility of T-wave alternans during the morning in the summer for the risk stratification of patients with Brugada syndrome.

Shogo Sakamoto1, Masahiko Takagi2, Jun Kakihara1, Yusuke Hayashi1, Atsushi Doi1, Kenichi Sugioka1, Minoru Yoshiyama1.   

Abstract

The prognostic value of the seasonal variations of T-wave alternans (TWA) and heart rate variability (HRV), and the seasonal distribution of ventricular fibrillation (VF) in Brugada syndrome (Br-S) is unknown. We assessed the utility of seasonal variations in TWA and HRV for risk stratification in Br-S using a 24-h multichannel Holter electrocardiogram (24-M-ECG). We enrolled 81 patients with Br-S (grouped according to their history of VF, n = 12; syncope, n = 8; no symptoms, n = 61) who underwent 24-M-ECG in all four seasons. Precordial electrodes were attached to the third (3L-V2) and fourth (4L-V2, 4L-V5) intercostal spaces. We determined the maximum TWA (max-TWA) values and calculated HRV during night and morning time periods for all seasons. During a follow-up period of 5.8 ± 2.8 years, 11 patients experienced new VF episodes and there was a peak in new VF episodes in the summer. The VF group had the greatest 3L-V2 max-TWA value during morning time in the summer among the three groups and showed higher 3L-V2 max-TWA value than in the other seasons. The cutoff value for the 3L-V2 max-TWA during morning time in the summer was determined to be 42 µV using ROC analysis (82 % sensitivity, 74 % specificity; p = 0.0006). Multivariate analysis revealed that a 3L-V2 max-TWA value ≥42 µV during morning time in the summer and previous VF episodes were predictors of future VF episodes. The 3L-V2 max-TWA value during morning time in the summer may be a useful predictor of future VF episodes in Br-S.

Entities:  

Keywords:  24-h multichannel Holter electrocardiogram; Brugada syndrome; Heart rate variability; Seasonal variation; T-wave alternans

Mesh:

Year:  2016        PMID: 27480879     DOI: 10.1007/s00380-016-0882-2

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  28 in total

1.  Guidelines for risks and prevention of sudden cardiac death (JCS 2010): – digest version –.

Authors: 
Journal:  Circ J       Date:  2012-01-12       Impact factor: 2.993

2.  Time-domain T-wave alternans is strongly associated with a history of ventricular fibrillation in patients with Brugada syndrome.

Authors:  Yuko Uchimura-Makita; Yukiko Nakano; Takehito Tokuyama; Mai Fujiwara; Yoshikazu Watanabe; Akinori Sairaku; Hiroshi Kawazoe; Hiroya Matsumura; Nozomu Oda; Hiroki Ikanaga; Chikaaki Motoda; Kenta Kajihara; Noboru Oda; Richard L Verrier; Yasuki Kihara
Journal:  J Cardiovasc Electrophysiol       Date:  2014-06-06

Review 3.  Brugada syndrome: a decade of progress.

Authors:  C Antzelevitch; P Brugada; J Brugada; R Brugada; W Shimizu; I Gussak; A R Perez Riera
Journal:  Circ Res       Date:  2002-12-13       Impact factor: 17.367

4.  Circadian and seasonal variations of ventricular tachyarrhythmias in patients with early repolarization syndrome and Brugada syndrome: analysis of patients with implantable cardioverter defibrillator.

Authors:  Sung-Hwan Kim; Gi-Byoung Nam; Seunghee Baek; Hyung Oh Choi; Ki Hun Kim; Kee-Joon Choi; Boyoung Joung; Hui-Nam Pak; Moon-Hyoung Lee; Sung Soon Kim; Seung-Jung Park; Young Keun On; June Soo Kim; Il-Young Oh; Eue-Keun Choi; Seil Oh; Yun-Shik Choi; Jong Il Choi; Sang Weon Park; Young-Hoon Kim; Man Young Lee; Hong Euy Lim; Young-Soo Lee; Yongkeun Cho; Jun Kim; Dong-Il Lee; Dae Kyoung Cho; You-Ho Kim
Journal:  J Cardiovasc Electrophysiol       Date:  2012-02-21

5.  A spontaneous Type 1 electrocardiogram pattern in lead V2 is an independent predictor of ventricular fibrillation in Brugada syndrome.

Authors:  Yukiko Nakano; Wataru Shimizu; Hiroshi Ogi; Kazuyoshi Suenari; Noboru Oda; Yuko Makita; Kenta Kajihara; Yukoh Hirai; Akinori Sairaku; Takehito Tokuyama; Yukiji Tonouchi; Shigeyuki Ueda; Taijiro Sueda; Kazuaki Chayama; Yasuki Kihara
Journal:  Europace       Date:  2010-01-31       Impact factor: 5.214

6.  T wave alternans does not assess arrhythmic risk in patients with Brugada syndrome.

Authors:  Paulus Kirchhof; Lars Eckardt; Sascha Rolf; Hans-D Esperer; Matthias Paul; Thomas Wichter; Helmut U Klein; Günter Breithardt; Dirk Böcker
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

7.  Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome.

Authors:  Masateru Takigawa; Takashi Noda; Wataru Shimizu; Koji Miyamoto; Hideo Okamura; Kazuhiro Satomi; Kazuhiro Suyama; Naohiko Aihara; Shiro Kamakura; Takashi Kurita
Journal:  Heart Rhythm       Date:  2008-08-28       Impact factor: 6.343

8.  Sleep apnoea induces cardiac electrical instability assessed by T-wave alternans in patients with congestive heart failure.

Authors:  Nobuhiro Takasugi; Kazuhiko Nishigaki; Tomoki Kubota; Kunihiko Tsuchiya; Kenji Natsuyama; Mieko Takasugi; Takahide Nawa; Shinsuke Ojio; Takuma Aoyama; Masanori Kawasaki; Genzou Takemura; Shinya Minatoguchi
Journal:  Eur J Heart Fail       Date:  2009-11       Impact factor: 15.534

9.  Decreased nocturnal standard deviation of averaged NN intervals. An independent marker to identify patients at risk in the Brugada Syndrome.

Authors:  Jean-Sylvain Hermida; Antoine Leenhardt; Bruno Cauchemez; Isabelle Denjoy; Geneviève Jarry; Fréderique Mizon; Paul Milliez; Jean-Luc Rey; Philippe Beaufils; Philippe Coumel
Journal:  Eur Heart J       Date:  2003-11       Impact factor: 29.983

10.  Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach.

Authors:  Pietro Delise; Giuseppe Allocca; Elena Marras; Carla Giustetto; Fiorenzo Gaita; Luigi Sciarra; Leonardo Calo; Alessandro Proclemer; Marta Marziali; Luca Rebellato; Giuseppe Berton; Leonardo Coro; Nadir Sitta
Journal:  Eur Heart J       Date:  2010-10-26       Impact factor: 29.983

View more
  3 in total

1.  Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome.

Authors:  Jun Kakihara; Masahiko Takagi; Yusuke Hayashi; Hiroaki Tatsumi; Atsushi Doi; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2017-03-31       Impact factor: 2.037

2.  Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.

Authors:  Tsukasa Kamakura; Mitsuru Wada; Kohei Ishibashi; Yuko Y Inoue; Koji Miyamoto; Hideo Okamura; Satoshi Nagase; Takashi Noda; Takeshi Aiba; Satoshi Yasuda; Kengo Kusano
Journal:  Heart Vessels       Date:  2017-05-18       Impact factor: 2.037

3.  Evaluation of the pulmonary artery potential using a 20-polar circumferential catheter and three-dimensional integrated intracardiac echocardiography.

Authors:  Masayuki Takahashi; Hisashi Yokoshiki; Hirofumi Mitsuyama; Taro Tenma; Masaya Watanabe; Rui Kamada; Ryo Sasaki; Yuki Chiba; Motoki Maeno; Toshihisa Anzai
Journal:  Heart Vessels       Date:  2018-06-21       Impact factor: 2.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.